SCHEMBL6710201

SCHEMBL6710201

O=C(Nc1ccc(Cl)cc1-c1nnn[nH]1)c1noc2ccc(NS(=O)(=O)c3ccc(F)cc3)cc12

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 1/20 0.39
HSD17B3 P37058 1/20 0.39
HSD17B2 P37059 1/20 0.39
KMT2A Q03164 4/20 0.38
MAPT P10636 2/20 0.38
LMNA P02545 1/20 0.38
TP53 P04637 1/20 0.38
HTT P42858 1/20 0.38
KIT P10721 3/20 0.38
HIF1A Q16665 2/20 0.38
FBP1 P09467 1/20 0.37
MEN1 O00255 3/20 0.37
POLB P06746 1/20 0.37
CLK1 P49759 1/20 0.37
GFER P55789 1/20 0.37
BRAF P15056 1/20 0.37
ALDH1A1 P00352 2/20 0.36
KDM4E B2RXH2 1/20 0.36
HPGD P15428 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6709048 0.94 KMT2A (0.38) TDP1HSD17B3HSD17B2KMT2AMAPT
SCHEMBL6710186 0.92 HIF1A (0.43) TDP1KMT2AMAPTHIF1AMEN1
SCHEMBL6707828 0.92 SLC10A6 (0.36) HSD17B3HSD17B2KMT2AMAPTKIT
SCHEMBL6708095 0.89 MEN1 (0.39) KMT2AMEN1CLK1BRAFALDH1A1
SCHEMBL6710218 0.88 HIF1A (0.43) KMT2ATP53HTTHIF1AMEN1
SCHEMBL6707764 0.87 HIF1A (0.41) KMT2AHIF1AMEN1POLBCLK1
SCHEMBL6708837 0.87 KMT2A (0.41) TDP1HSD17B3HSD17B2KMT2AMAPT
SCHEMBL6713276 0.86 HIF1A (0.43) TDP1KMT2AMAPTLMNATP53
SCHEMBL6711755 0.85 ALDH1A1 (0.36) KMT2AMAPTTP53MEN1POLB
SCHEMBL6708030 0.83 ALDH1A1 (0.39) KMT2AHIF1AMEN1POLBGFER

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040142981-A1 Antibacterial benzoic acid derivatives PHARMACIA & UPJOHN COMPANY 2004-07-22 US disclosed
WO-2004018461-A2 ANTIBACTERIAL BENZOIC ACID DERIVATIVES PHARMACIA & UPJOHN COMPANY LLC (US) 2004-03-04 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040142981-A1 Antibacterial benzoic acid derivatives GABRD, PHB1, GABBR1 TDP1 2977/4885HSD17B3 2919/4885HSD17B2 2564/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.